https://rjrindex.com/articles/real-world-validation-of-the-2025-imwg-high-risk-criteria-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/20-year-trends-in-socioeconomic-disparities-in-breast-cancer-care-for-patients-aged-lt-65-years-ol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-a-single-arm-phase-ii-clinical-trial-of-gemcitabine-cisplatin-and-nab-paclitaxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-reflexive-next-generation-sequencing-on-treatment-initiation-in-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-burden-of-hepatocellular-carcinoma-and-diabetes-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-immune-checkpoint-inhibitor-on-the-quality-of-life-of-patients-with-advancedmetastatic-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/essential-but-unaffordable-real-world-costs-of-who-essential-cancer-medicines-in-a-low-income-setti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-patients-with-metastatic-renal-cell-carcinoma-mrcc-who-complete-18-months-of-first-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-chemotherapy-induced-adverse-events-in-patients-with-metastatic-pancreatic-ductal-aden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-dm002-an-anti-muc1her3-bispecific-antibody-drug-conjugate-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-sacituzumab-govitecan-sg-versus-trastuzumab-deruxtecan-t-dxd-in-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-trial-participation-among-adolescents-and-young-adults-diagnosed-with-cancer-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-and-cost-related-access-barriers-to-specialty-oral-anticancer-medications-for-blood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-overall-survival-and-quality-of-life-to-rank-first-line-therapies-for-advanced-urothelia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg1-fusions-in-non-small-cell-lung-cancer-nsclc-prevalence-clinical-and-molecular-features-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-actionable-driver-alterations-and-efficacy-of-targeted-therapy-in-lung-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-ib-trial-to-evaluate-neoadjuvant-immunotherapy-combination-of-nivolu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-toripalimab-combined-with-inetetamab-pertuzumab-and-nab-paclitaxel-in-her2-positive-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-molecular-subtype-guided-chemotherapy-free-neoadjuvant-strategy-using-shr-a1811-plus-pertuzumab-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-guided-pathology-biomarker-as-a-predictor-of-benefit-of-adjuvant-docetaxel-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ascent-03-efficacy-by-biomarker-subgroup-with-sacituzumab-govitecan-sg-vs-chemotherapy-chemo-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-quality-improvement-initiative-to-increase-smoking-cessation-assistance-in-commission-on-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbiome-derived-bile-acids-and-association-with-dietary-fiber-intake-to-anti-tumor-responses-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-dynamic-changes-in-tumor-markers-with-overall-survival-in-patients-with-mucinous-appe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/turning-silence-into-rhythm-outcomes-of-a-school-based-icancer-olympiadi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-associated-host-factors-and-intracranial-disease-phenotype-in-breast-cancer-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extent-of-resection-and-survival-in-iidhi-mutant-who-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-phase-1-study-of-ebc-129-a-first-in-class-anti-n256-glycosylated-ceacam5-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-first-recurrence-from-idh-wildtype-glioblastoma-with-re-resection-or-stereotactic-radi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-prostate-cancer-and-tobacco-use-related-mortality-among-adults-aged-55-ye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trend-from-multiple-myeloma-with-hypertensive-diseases-as-a-contributing-cause-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-evaluating-nivolumab-in-patients-with-recurrent-idh-mutant-gliomas-with-and-without-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-real-world-patterns-of-precision-medicine-in-metastatic-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burnout-among-early-career-oncologists-in-latin-america-a-regional-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cumulative-barriers-to-access-an-ai-driven-analysis-of-eligibility-restrictions-clinical-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/applying-learning-science-principles-lsp-in-a-workshop-ws-for-hematology-and-oncology-hemonc-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-where-you-live-matter-state-level-variation-in-liver-cancer-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-non-interventional-multisite-evaluations-of-traqinform-immuno-algorithmic-quantitative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-and-molecular-characterization-of-iarid1ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuroprotective-potential-of-bold-100-when-utilized-in-combination-with-folfox-for-the-treatment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extracellular-matrix-derived-liquid-biopsy-for-predicting-response-in-patients-with-biliary-tract-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-long-read-sequencing-to-resolve-cryptic-genomic-instability-across-cancer-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-risk-stratification-in-a-us-based-database-to-identify-subgroups-of-patients-with-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-and-validating-immune-effector-dysfunction-as-a-biomarker-in-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-glp-1-receptor-agonism-on-anthracycline-and-her2-targeted-therapy-induced-cardiac-dysfunc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-language-model-assisted-decision-making-in-multidisciplinary-tumor-boards-for-colorectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-nodal-nexus-assessing-the-lymph-node-dynamics-and-outcomes-in-node-positive-carcinoma-of-the-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-earlier-time-of-first-cycle-immunotherapy-administration-on-progression-free-survival-in-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disaggregated-lung-cancer-mortality-trends-in-asian-american-native-hawaiian-and-pacific-islander 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-vs-delayed-bone-modifying-agent-initiation-and-zoledronic-acid-vs-denosumab-in-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-postoperative-recurrence-in-non-small-cell-lung-cancer-using-machine-learning-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-tivozanib-in-favorable-and-very-favorable-risk-metastatic-renal-cell-carcinoma-real-wor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trajectories-of-cervical-cancer-patients-through-the-health-systems-of-colombia-and-guatemala 2026-08-24 monthly 0.7 https://rjrindex.com/articles/continued-cns-penetrant-tki-therapy-with-or-without-local-cns-therapy-after-brain-metastasis-diagnos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/duffy-null-status-and-cytopenias-following-bcma-directed-car-t-therapy-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-immune-mediated-adverse-events-and-clinical-outcomes-in-patients-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inb-200-phase-i-study-and-characterization-of-gene-modified-autologous-gamma-delta-ghd-t-cells-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bl0175-a-novel-nano-mediated-polypeptide-conjugate-of-protein-degrader-in-patients-pts-with-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-disability-burden-of-pancreatic-cancer-in-the-united-states-compared-with-high-socio-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-heterogeneity-and-genetic-testing-utilization-in-glioblastoma-patients-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-darolutamide-plus-leuprolide-acetate-in-hormone-therapy-naive-recurrent-andor-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-strategies-in-metastatic-nsclc-after-progression-to-immuno-chemotherapy-a-random-effects 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-of-nectin-4-in-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-platinum-based-chemotherapy-vs-observation-after-resection-of-stage-i-iia-n0-nsclc-a-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-intratumoral-it-ruxotemitide-ltx-315-in-combination-with-pembrolizumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-randomised-placebo-controlled-trial-of-melatonin-for-the-management-of-sleep-disturbance-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-underuse-of-radiation-therapy-in-older-adults-with-high-risk-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-and-immune-microenvironment-remodeling-with-neoadjuvant-trastuzumab-deruxtecan-in-her2-positiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-gp78-spatial-aggressiveness-index-gp78-sai-a-race-independent-ai-driven-biomarker-for-precisi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-computational-histology-artificial-intelligence-chai-powered-predictive-biomarker 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-from-myocardial-infarction-in-gi-malignancy-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/readmissions-after-cns-tumor-surgery-and-associations-with-social-determinants-of-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-first-line-1l-therapies-for-advanced-urothelial-carcinoma-auc-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immunoglobulin-replacement-with-infection-and-mortality-outcomes-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-routine-prognostic-blood-tests-in-evaluating-chances-of-safely-prolonged-survival-across-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fatal-infection-associated-adverse-events-with-b-cell-maturation-antigen-directed-therapies-in-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-the-association-between-primary-insomnia-and-early-onset-hormone-related-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telehealth-use-and-end-of-life-care-outcomes-among-medicare-decedents-with-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-and-correlative-analysis-of-entinostat-e-plus-pembrolizumab-p-in-patients-pts-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-therapeutic-implications-of-hrr-gene-mutations-in-non-cutaneous-melanoma-association 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-based-predictive-models-for-recurrence-and-recurrence-free-survival-in-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-progression-treatment-strategies-and-immunotherapy-rechallenge-sensitivity-following-chemoradia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-improved-prognostication-using-petct-radiomics-in-relapsedrefractory-tp53-aberrant-diff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-combination-therapies-for-untreated-chronic-lymphocytic-leukemia-a-network-meta-analysis-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ciltacabtagene-autoleucel-in-lenalidomide-refractory-multiple-myeloma-responding-to-bridging-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-socioeconomic-factors-on-patient-reported-provider-communication-among-patients-with-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aberrant-somatic-hypermutation-in-large-b-cell-lymphomas-and-its-relationship-to-mutational-signatur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-multi-cancer-early-detection-mced-test-in-a-private-practice-adoption-perfor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-generative-ai-based-clinical-decision-support-system-for-surgical-extent-in-thyroid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-tolerability-of-duvelisib-in-relapsedrefractory-peripheral-t-cell-lymphoma-a-multicen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/restrictive-eligibility-criteria-in-fda-approved-oncology-trials-following-asco-guideline-updates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-heterogeneity-of-structural-inequities-in-diagnostic-delay-and-survival-in-early-onset-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-non-inferiority-trial-of-an-ehealth-delivery-alternative-for-cancer-genetic-testing-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-reasons-patients-do-not-join-a-cancer-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distant-recurrence-free-survival-in-invasive-lobular-carcinoma-ilc-with-isolated-tumor-cells-does 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-optimized-dosage-for-zelenectide-pevedotin-in-locally-advancedmetastatic-urothelial-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-outcomes-and-postoperative-complications-of-robotic-versus-conventional-nipple-sparing-mast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zelenectide-pevedotin-bt8009-monotherapy-in-previously-treated-metastatic-urothelial-carcinoma-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lung-cancer-screening-in-patients-diagnosed-with-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-triage-aware-neuro-symbolic-approach-for-clinical-trial-matching-in-oncology-real-world-validatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-of-day-tod-of-single-agent-immune-checkpoint-inhibitor-ici-on-survival-in-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fgf4-mediated-resistance-to-combined-anti-angiogenic-and-immunotherapy-in-esophageal-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/additional-health-related-quality-of-life-hrqol-analysis-from-destiny-gastric04-dg-04-a-randomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-belantamab-mafodotin-plus-bortezomib-and-dexamethasone-bvd-vs-standard-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validity-of-ultrasensitive-single-digit-parts-per-million-ctdna-detection-in-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-hrqol-with-pembrolizumab-or-observation-for-high-risk-muscle-invasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-iesr1i-multi-pathway-genomic-drivers-of-endocr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-equivalence-of-brand-name-vs-generic-imatinib-in-neoadjuvant-ikiti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-disitamab-vedotin-plus-carboplatin-in-her2-expressing-advanced-ovarian-cancer-a-prospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-survival-disparities-in-two-population-based-cohorts-of-adults-with-early-onset-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-load-change-as-a-functional-biomarker-for-prognosis-and-treatment-modulation-in-metastatic-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thematic-game-intervention-as-a-novel-psychosocial-support-to-reduce-sedation-needs-and-anxiety-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-infancy-to-young-adulthood-exploring-the-divergent-genomic-mechanisms-that-drive-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-and-outcomes-of-lenalidomide-in-mds-with-low-blasts-and-isolated-deletion-5q 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-disitamab-vedotin-plus-pd-1-inhibitor-versus-platinum-based-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-immune-checkpoint-inhibitors-in-solid-tumor-patients-with-hepatitis-c-a-real-world-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-subtype-specific-patterns-of-clinically-relevant-antibody-drug-conjugate-targets-in-sarcoma-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-checkpoint-inhibitor-resistance-mechanisms-in-leiomyosarcoma-through-enrichment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-among-hospitalized-patients-with-pancreatic-cancer-a-national-inpatient-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-and-temporal-evolution-of-mutational-signatures-in-metastatic-lobular-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/capture-a-phase-ii-trial-evaluating-alpelisib-fulvestrant-vs-capecitabine-in-advanced-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-effector-cell-associated-enterocolitis-iec-ec-incidence-and-characterization-in-cilta-cel-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicity-assessment-clinic-as-an-efficacious-tool-to-provide-fast-care-to-oncology-patients-on-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intersecting-rural-racial-and-medicaid-disparities-in-cervical-cancer-outcomes-across-north-caroli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magnitude-and-timing-of-clinical-benefit-associated-with-pathologic-complete-response-in-perioperati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-surrogate-models-to-predict-long-term-cardiovascular-effects-of-immune-check 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-survival-and-long-term-gastrointestinal-outcomes-of-ipilimumabnivolumab-vs-durvalumabt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elegant-elacestrant-versus-standard-endocrine-therapy-et-in-women-and-men-with-node-positive-est 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-leukocytosis-on-outcomes-in-patients-with-myelofibrosis-a-propensity-matched-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-global-and-regional-burden-of-leukemia-from-1990-2023-a-systematic-analysis-for-the-global-burd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-of-safetyefficacy-using-lurbinectedin-combined-with-ipilimumab-and-nivolumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trofuse-022engot-ov84gog-3103-part-2-a-phase-3-study-of-maintenance-therapy-with-sacituzumab-tiru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-value-of-romiplostim-for-management-of-chemotherapy-induced-thrombocytopenia-in-gastrointes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/framework-01-a-two-part-phase-3-study-of-sofetabart-mipitecan-versus-chemotherapy-or-mirvetuximab-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-trial-of-sentinel-node-biopsy-omission-after-neoadjuvant-systemic-therapy-in-clinically 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-time-trial-phase-ii-randomized-controlled-trial-of-time-of-day-specified-nivolumab-and-ipilimum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-trial-evaluating-an-optimized-b7-h3xcd3-t-cell-engager-for-treatment-of-solid-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2b-randomized-blinded-placebo-controlled-trial-to-investigate-the-efficacy-and-safety-of-vis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stella-a-dose-expansion-of-the-atr-kinase-inhibitor-alnodesertib-art0380-administered-orally-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-treatment-approaches-in-advanced-hrd-positive-brcam-and-brcawt-ovarian-cancer-in-the-russi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nice-til-nkg2d-carmbil15tegfr-transduced-tils-and-antitumor-activity-via-dual-tcr-hla-and-nkg2d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-outcomes-after-bispecific-t-cell-engager-therapy-in-multiple-myeloma-a-propensity-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-network-analysis-of-symptoms-in-women-with-metastatic-breast-cancer-undergoing-systemic-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cure-ai-as-a-predictor-of-tigit-as-a-therapeutic-target-in-pediatric-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-concept-to-clinic-implementation-and-early-outcomes-of-mced-screening-at-rush-health-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-inavolisib-associated-hyperglycemia-in-metastatic-hormone-receptor-positive-hr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-strategies-for-pi3kakt-inhibitor-induced-hyperglycemia-in-hrher2-metastatic-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-treatment-pathway-profiling-and-platinum-resistance-in-high-grade-serous-ovarian-cancer-discov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-and-egfr-inhibition-for-high-risk-cutaneous-squamous-cell-carcinoma-in-immunosuppressed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/twenty-years-of-colon-cancer-epidemiology-and-treatment-patterns-in-sao-paulo-brazil-a-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-sex-specific-trends-in-heart-pericardial-and-mediastinal-tumors-a-population-based-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acupuncture-for-psychoneurological-symptoms-in-breast-cancer-symptom-specific-response-and-sustaina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-cadonilimab-plus-ak117-and-chemotherapy-chemo-in-advanced-gastric-or-gastroesophag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-on-routine-histopathology-to-enable-one-year-survival-prediction-in-pancreatic-ductal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sulfidogenic-bacteria-and-the-risk-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/provider-insights-and-utilization-of-psychiatric-pharmacogenomics-for-patients-with-comorbid-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tbcrc-058-a-randomized-phase-ii-study-of-enzalutamide-enzalutamide-with-mifepristone-and-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-immune-checkpoint-inhibitor-therapy-after-curative-intent-resection-or-ablation-for-high-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-patient-engagement-with-an-oncology-chatbot-thematic-and-sentiment-analysis-of-medica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tagnot-a-phase-1b2-tumor-agnostic-study-of-the-selective-anti-fgfr1-monoclonal-antibody-om-rca-01 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-cardio-renal-outcomes-with-glp-1ra-and-sglt2i-in-anthracycline-treated-diabetic-women-with-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-preference-for-subcutaneous-vs-intravenous-immune-therapy-psi-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-ds9051-a-novel-targeted-protein-degradation-molecule-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matches-novel-a-randomized-controlled-trial-in-progress-of-hospital-at-home-hah-versus-inpatient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effects-of-specialized-sardio-oncological-care-on-the-duration-of-tki-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-double-blinded-study-of-the-efficacy-of-oleogel-s10-ap101-gel-for-the-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learningartificial-intelligence-in-liquid-biopsy-based-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neighborhood-social-vulnerability-and-chemotherapy-response-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/calibration-of-commercial-ai-chatbots-for-cancer-symptom-recognition-a-pilot-methodology-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-first-in-human-open-label-study-evaluating-the-safety-tolerability-pharmacokinetics-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-treatment-impact-on-metabolism 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-four-subtype-model-of-cervical-cancer-based-on-ipik3cai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-palliative-care-and-symptom-directed-care-utilization-in-pancreatic-cancer-a-national-epic-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-burden-of-tumor-lysis-syndrome-all-vs-aml-using-a-national-us-dataset 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-facilitators-of-advance-care-planning-in-cancer-patients-in-southeast-alabama-an-obser 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-a-vertically-integrated-care-system-on-mortality-risks-in-insured-patients-by-race-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-systemic-therapy-for-triple-negative-breast-cancer-a-safety-net-health-systems-experie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-chemotherapy-on-gonadal-function-in-pubertal-children-with-hodgkin-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/observation-on-the-application-effect-of-biological-polysaccharide-in-radiation-induced-oral-mucosit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-arterial-and-venous-vascular-complications-after-radiotherapy-for-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hipec-combined-with-pd-1-inhibitor-chemotherapy-in-conversion-therapy-for-advanced-gastric-cancer-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-facilitators-to-teleoncology-care-delivery-for-cognitively-impaired-older-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-diverse-participation-in-cancer-clinical-trials-evaluating-theory-based-recruitment-messa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disco-app-feasibility-and-acceptability-of-an-intervention-to-reduce-the-financial-burden-of-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-locoregional-colorectal-cancer-incidence-by-socioeconomic-factors-in-us-adults-aged-45-49 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-osimertinib-rechallenge-after-osimertinib-induced-interstitial-lung-disease-in-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hope-hematologyoncology-practical-education-a-pilot-curriculum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-first-line-iegfri-tki-dose-reduction-on-survi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-toxicity-associated-hospitalizations-and-inpatient-outcomes-among-gastrointestinal-maligna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-generative-model-assisted-clinical-decision-support-system-for-the-postoperative-management-of-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disparities-in-access-to-biomarker-testing-for-gastrointestinal-cancers-a-nationwide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-induced-autoimmune-type-1-diabetes-clinical-characteristics-and-managem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-covid-19-pandemic-on-outcomes-in-malignant-bowel-obstruction-a-national-inpatient-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-biomarker-directed-therapy-utilization-in-metastatic-colorectal-cancer-a-real-world-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-treatment-outcomes-among-iegfri-mutation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-post-prostatectomy-management-a-machine-learning-tool-to-identify-low-risk-patients-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tele-nutritional-collaborative-care-in-patients-with-stage-iv-gastrointestinal-cancer-receiving-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-adjuvant-abemaciclib-in-high-risk-hrher2-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-glp-1-receptor-agonists-mitigate-cancer-progression-a-propensity-matched-analysis-across-seven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-benefit-of-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-concomitant-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-overall-survival-analysis-and-examination-of-subsequent-therapy-in-endometrial-cancer-ec-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-monitoring-for-post-surgical-molecular-residual-disease-in-patients-with-stage-i-iiib-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atezolizumab-for-alveolar-soft-part-sarcoma-a-clinical-trial-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-comments-on-the-lunar-trial-in-oligorecurrent-hormone-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-grade-3-and-grade-4-immunotherapy-induced-dermatologic-toxicities-at-a-tertiary-medical-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gp-regimen-chronomodulated-induction-chemotherapy-combined-with-concurrent-chemoradiotherapy-for-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-intra-arterial-liver-directed-therapies-in-unresectable-neuroendocrine-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-adjuvant-botensilimab-in-combination-with-balstilimab-in-patients-with-microsatelli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reprogramming-tumor-associated-immune-cells-with-z-007-a-first-in-class-systemic-tlr789-agonist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-net-coverage-instability-during-cancer-care-and-association-with-overall-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-tp53-pathway-alterations-by-treatment-type-the-md-anderson-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-slide-imaging-based-prediction-of-immunohistochemistry-markers-and-surgical-pathological-featu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-landscape-of-pten-protein-expression-and-its-relationships-with-her2-and-psma-in-chinese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-overall-survival-in-recurrentmetastatic-head-and-neck-squamous-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-emerging-disparity-in-young-onset-lung-adenocarcinoma-evidence-from-a-seer-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dart-nciswog-s1609-comprehensive-results-from-dual-checkpoint-inhibition-with-ctla-4-and-pd-1-bl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-signature-of-temozolomide-treatment-effect-heterogeneity-in-idh-wildtype-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitors-after-platinum-based-therapy-for-refractory-or-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-cancer-risk-and-metastatic-outcomes-in-patients-with-metabolic-dysfunction-associated-ste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionable-genomic-alterations-and-survival-in-ikrasi-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-stage-prediction-using-longitudinal-ct-imaging-compared-with-single-timepoint-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-btae-haic-combined-with-lenvatinib-and-sintilimab-for-infiltrative-hepatocellular-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-impact-of-concomitant-medication-in-extensive-stage-small-cell-lung-cancer-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-evaluation-of-a-designated-oncology-pharmacist-in-hemato-oncology-outpatient-care-a-random 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-pegylated-liposomal-doxorubicin-dacarbazine-and-toripalimab-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-variation-in-live-birth-incidence-and-access-to-assisted-reproductive-services-amon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-trial-of-dexamethasone-mouthwash-to-prevent-chemotherapy-induced-oral-mucosit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omic-profiling-to-identify-rna-protein-concordance-and-post-transcriptional-dysregulation-in-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-combined-with-toripalimab-for-triple-negative-breast-cancer-a-prospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-for-advanced-or-metastatic-chemotherapy-refractory-thymic-epithelial-tumor-a-single-arm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fertility-concerns-counseling-and-preservation-in-aya-females-with-early-stage-breast-cancer-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alirocumab-plus-cemiplimab-in-immuno-refractory-metastatic-nsclc-a-single-arm-multi-center-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-dual-checkpoint-blockade-versus-pd-1vegf-inhibitor-combination-as-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-a-survival-paradox-in-young-onset-lung-adenocarcinoma-racial-and-ethnic-disparities-in-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-outcomes-of-immune-checkpoint-inhibitors-in-metastatic-melanoma-later-relapse-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-the-phase-iii-octava-trial-clinical-benefit-of-low-dose-anti-ctla-4-plus-anti-pd-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-real-world-outcomes-of-atezolizumab-and-pembrolizumab-based-regimens-in-non-squamous-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-an-igf1r-rna-activation-signature-with-allostatic-load-and-time-to-castration-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-tumor-burden-an-automated-estimate-of-scan-level-volumetric-lung-tumor-burden-from-routine-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/moving-beyond-imaging-in-metastatic-castration-resistant-prostate-cancer-liquid-biopsy-cfna-profili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficientnetv2-guided-knowledge-distillation-for-breast-ultrasound-diagnosis-scalable-deep-learning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-of-origin-prediction-using-methylation-signals-from-plasma-cell-free-dna-cfdna-real-world-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donor-dependent-amplification-capacity-and-phenotype-of-ex-vivo-expanded-inkt-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-nab-paclitaxel-and-s-1-combined-with-tislelizumab-as-first-line-treatment-for-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-screening-is-heating-up-a-novel-thermophysics-based-ai-modality-for-screening-subject 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-influencing-the-selection-of-checkmate-9la-nivolumab-ipilimumab-and-chemotherapy-regimen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-predictors-and-recovery-of-acute-chemotherapy-related-left-ventricular-dysfunction-in-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-immunoprofiling-of-peripheral-blood-using-foundation-models-of-the-immune-system-for-pred 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peak-inflammatory-stress-versus-baseline-neutrophil-to-lymphocyte-ratio-nlr-for-prediction-of-in-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-radiographic-responses-to-trastuzumab-deruxtecan-in-molecularly-defined-ependymomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-enfortumab-vedotin-ev-or-pembrolizumab-p-interruption-in-metastatic-urothel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-ml-model-integrating-cell-death-pathways-as-a-prognostic-and-predictive-biomarker 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-dose-furmonertinib-in-iegfri-mutant-nsclc-with-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/linking-t-cell-receptor-dynamics-to-outcomes-in-neoadjuvant-treated-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytical-validation-of-a-plasma-based-cfdna-ngs-assay-guardant360-liquid-cdx-for-comprehensive-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-neoadjuvant-chemotherapy-nac-versus-upfront-surgery-us-in-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tailoring-post-neoadjuvant-staging-to-tumor-biology-a-comparison-of-neo-bioscore-rcb-and-patholog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-escalation-of-axillary-surgery-in-clinically-node-negative-early-stage-hr-positive-her2-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-vulnerability-interaction-and-real-world-treatment-outcomes-in-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-invasive-mrd-monitoring-and-profiling-of-clonal-evolution-by-ctdna-in-patients-with-advanced-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-true-burden-of-immune-related-colitis-in-lung-cancer-through-large-language-model-enab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b-dose-expansion-study-of-imc-002-a-anti-cd47-monoclonal-antibody-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-multimodal-machine-learning-models-for-predicting-overall-survival-in-patients-with-non-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-modeling-of-cci-cci-faceage-thymic-health-and-os-among-older-adults-with-early-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-pancreatic-carcinoma-mortality-among-adults-with-type-2-diabetes-mellitus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-and-safety-of-bm201-intra-tumoral-injection-and-radiotherapy-in-advanced-solid-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-dose-escalated-wbrt-on-survival-in-nsclc-leptomeningeal-metastases-a-multimodal-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-pharmacokinetic-and-preliminary-efficacy-of-snc115-in-patients-with-relapsedrefractory-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversational-ai-assisted-exploratory-data-analysis-ca-eda-a-comparative-evaluation-of-commercia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-sudden-cardiac-death-among-pancreatic-cancer-patients-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-trastuzumab-deruxtecan-after-her2-tki-exposure-in-her2-exon-20-insertion-positive-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-stratified-evaluation-of-subsequent-primary-malignancy-risk-in-patients-with-primary-lynch-syndr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-and-imaging-predictors-of-pathologic-complete-response-after-neoadjuvant-chemoimmu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-hla-class-ii-diversity-as-a-predictor-of-survival-selectively-in-mhc-silenced-gliomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osimertinib-plus-savolitinib-in-osimertinib-resistant-non-small-cell-lung-cancer-with-low-level-gene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-3d-tumorwide-multi-omic-atlas-of-intratumoral-heterogeneity-in-iidhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-demographic-disparities-in-cardiovascular-disease-cvd-and-hepatocellular-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rezvilutamide-rez-versus-bicalutamide-bic-plus-androgen-deprivation-therapy-adt-in-high-volume 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-toxicity-healthcare-utilization-and-survival-after-car-t-cell-therapy-versus-bispecific-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ori-ttv-particles-on-in-vivo-car-t-cell-engineering-for-the-treatment-of-hematologic-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-prognostic-performance-of-an-ai-based-model-in-clinically-low-risk-hrher2-early-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-toripalimab-in-non-small-cell-lung-cancer-clinical-outcomes-and-safety-from-a-large-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-health-intervention-for-comorbid-insomnia-and-neurocognitive-impairment-in-adult-survivors-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-malignant-peripheral-nerve-sheath-tumors-in-neurofibromatosis-type-1-and-sporadic-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-effects-of-treatment-with-dabrafenib-d-andor-trametinib-t-in-pediatric-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-cumulative-exposure-of-various-endocrine-disrupting-chemicals-and-association-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-camrelizumab-combined-with-docetaxel-and-carboplatin-as-neoadjuvant-therapy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metabolic-and-inflammatory-marker-elevations-and-associations-with-hormone-therapy-usage-in-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bowel-function-after-sphincter-preserving-treatment-with-neoadjuvant-therapy-for-low-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-prognostic-roles-of-iidhi-mutation-and-high-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/negative-effect-of-malignant-pleural-effusion-on-the-efficacy-of-immunotherapy-via-il-6-mediated-abs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-gt719-an-off-the-shelf-car-nkt-therapy-in-adults-with-relapsed-or-refractor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/common-symptoms-quality-of-life-and-lifestyle-factors-reported-by-cancer-survivors-attending-the-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-residual-disease-mrd-detection-using-an-ultra-sensitive-assay-in-a-prospective-colorecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-cabozantinib-treatment-with-and-without-immune-checkpoint-inhibition-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-puxitatug-samrotecan-puxi-sam-azd8205-in-patients-with-biliary-tract-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tams-in-appendiceal-cancer-association-with-metabolic-remodeling-prognosis-and-response-to-intra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-routine-electronic-symptom-monitoring-with-reduced-opioid-use-in-patients-with-head-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-clinical-and-economic-signatures-of-car-t-cell-therapy-in-dlbcl-across-demographic-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pollution-and-progression-air-quality-and-stage-of-lung-cancer-diagnosis-across-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-nalirifox-in-patients-with-metastatic-pancreatic-ductal-adenocarcinoma-and-pre-existing-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-pharmacokinetics-and-immunogenicity-of-hlx6018-a-monoclonal-antibody-targeting-the-garptg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progestin-only-implant-and-breast-cancer-risk-in-adolescents-and-premenopausal-women-a-systematic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-embolism-related-mortality-in-pancreatic-cancer-patients-aged-45-years-in-the-united-stat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/wire-guided-versus-radio-guided-localization-for-non-palpable-occult-lesion-in-breast-tissue-a-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sustained-mrd-negativity-for-up-to-5-years-on-long-term-outcome-of-transplant-eligible-new 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-multicenter-open-label-study-of-hsk46575-in-patients-with-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-molecular-landscape-and-clinical-nomogram-of-cholangiocarcinoma-harboring-escat-i-alterations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-involvement-at-the-end-of-life-in-advanced-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-lymphodepletion-crp-and-ferritin-risk-stratification-as-a-predictor-of-early-immune-toxicities-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-immunogenomic-features-of-cancers-arising-in-solid-organ-transplant-recipients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perceptions-of-medicaid-coverage-and-care-experiences-among-long-term-survivors-of-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-mrd-combined-with-codex2-to-identify-high-risk-colorectal-cancer-with-potential-sensitivity-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-influencing-early-readmission-among-breast-lung-and-colorectal-cancer-patients-admitted-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-operative-neurologic-outcomes-in-children-with-wnt-medulloblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-online-bone-marrow-transplant-bmt-unit-medical-education-platform-for-internal-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-response-and-clinical-outcomes-of-patients-with-triple-negative-invasive-apocrine-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-ibrafi-mutant-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-point-of-care-clinical-decision-support-system-to-optimize-total-cost-of-care-whil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-chemotherapy-with-salvage-surgery-for-locoregionally-recurrent-nasopharyngeal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/worst-case-scenarios-triggers-and-coping-strategies-among-head-and-neck-cancer-caregivers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synergistic-antitumor-activity-of-glix1-a-small-molecule-tet2-activator-in-combination-with-parp-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triple-negative-breast-cancer-real-world-evidence-from-a-national-oncologic-reference-center-in-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-gleason-score-concordance-after-radical-prostatectomy-a-seer-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-z-endoxifen-on-estrogen-receptor-signaling-inhibition-across-clinically-relevant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-immunocompetent-blood-cells-in-patients-with-recurrent-ovarian-cancer-depending-on-platin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinically-deployable-deep-learning-model-for-decision-support-and-specimen-triage-in-colorectal-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subtype-specific-pi3k-pathway-and-tp53-alteration-patterns-in-breast-cancer-a-cross-cohort-comparis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-immune-checkpoint-inhibition-vs-anti-pd-1-monotherapy-in-metastatic-ibraf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-immune-checkpoint-inhibitors-in-combination-with-tyrosine-kinase-inhibitors-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-cause-of-death-among-patients-with-subsequent-primary-malignancies-after-cutaneous-melan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variations-in-postoperative-patient-reported-outcomes-pros-attributed-to-patients-surgeons-or-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aya-power-an-innovative-and-sustainable-virtual-model-for-aya-oncology-education 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-low-dose-lorlatinib-in-ialki-mut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-para-cervical-boost-with-volumetric-modulated-arc-therapy-on-local-control-in-locally-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-sequencing-methods-to-detect-chimeric-sites-for-ex-vivo-cell-and-gene-therapy-and-developi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-involving-colon-cancer-and-atrial-fibrillation-in-the-united-states1999-2023-a-cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vaccination-patterns-among-patients-receiving-icis-a-practice-informing-implementation-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-expansion-of-hematopoietic-cell-transplantation-in-patients-aged-gt75-years-a-cibmtr-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-structured-patient-advocacy-led-communication-model-to-improve-awareness-trust-and-access-to-onc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-eligibility-burden-on-survival-time-in-pancreatic-cancer-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uniportal-versus-multiportal-video-assisted-thoracic-surgery-vats-in-esophageal-cancer-a-systemat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-early-discharge-clinic-a-safe-and-efficient-model-for-intensive-outpatient-management-of-hemato-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-navigation-pilot-preliminary-results-of-nurse-outreach-support-for-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-cytostatic-properties-of-berberine-derivatives-on-a-cell-culture-of-acute-t-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epstein-barr-virus-reactivation-and-post-transplant-lymphoproliferative-disorder-following-letermovi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-lung-resection-and-inpatient-mortality-among-us-lung-cancer-patients-2010-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-supportive-care-access-and-financial-burden-associated-with-chemotherapy-induced-alop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-between-knowledge-attitudes-and-practice-regarding-physical-activity-and-exercise 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-from-diagnosis-to-car-t-as-a-predictor-of-outcomes-in-transformed-follicular-lymphoma-a-cibmtr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-glucagon-like-peptide-1-receptor-agonists-in-patients-receiving-chimeric-antigen-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-continuous-infusion-versus-intravenous-push-followed-by-infusion-5-fluoroura 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-analysis-of-first-line-treatment-for-advanced-melanoma-in-a-public-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/photodynamic-therapy-combined-with-biliary-drainage-for-extrahepatic-cholangiocarcinoma-a-propensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-existing-cancer-on-short-term-outcomes-and-mortality-following-left-ventricular-assist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-randomized-open-label-trial-of-sacituzumab-govitecan-plus-nivolumab-or-sacituzumab-goviteca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitor-rechallenge-in-advanced-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1a1b-study-of-lb-lr1109-an-anti-lilrb1-monoclonal-antibody-as-monotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-metabolic-predictors-of-complete-response-after-neoadjuvant-immune-checkpoint-blockade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sharing-geriatric-and-functional-status-assessment-data-with-older-adults-who-have-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progress-report-of-a-phase-2-study-of-bpm31510-a-lipid-nano-dispersion-of-oxidized-coq10-with-vita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-bgm-2121-in-patients-with-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-light-dose-escalation-study-in-locally-advanced-pancreatic-ductal-adenocarcinoma-intra-arte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fatty-acid-degradation-fad-guided-comprehensive-therapy-for-unresectable-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-double-blind-placebo-controlled-study-of-a-pasritamig-plus-best-supportive-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-hematologic-malignancy-mortality-in-older-survivors-of-gastrointestinal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancies-in-patients-with-chronic-lymphocytic-leukemia-a-seer-analysis-2000-202 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-related-fatigue-research-at-the-national-institutes-of-health-nih-from-2015-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jak-inhibitors-vs-traditional-therapy-for-myelofibrosis-a-meta-analysis-of-randomized-clinical-tria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-physical-disability-status-and-up-to-date-colorectal-cancer-screening-a-cross-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-equity-in-clinical-trials-through-decentralized-methodology-a-national-position-statement 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-assisted-treatment-decision-making-for-cancer-multidisciplinary-team-meeting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-trade-offs-between-efficacy-and-toxicity-real-world-outcomes-of-dapsone-vs-atovaquone-for-pneum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/technical-performance-of-online-adaptive-radiotherapy-in-managing-inter-fractional-anatomical-deform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-and-epigenetic-modulation-of-car-t-cell-responses-a-systematic-review-exploring-the-influen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-survivorship-transitions-utilizing-an-ehr-visual-alert 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impacts-of-the-2025-southern-california-wildfires-among-childhood-cancer-patients-and-survi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-specific-associations-between-clinical-demographic-and-treatment-factors-and-long-term-survi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimated-clinical-benefits-of-timely-biomarker-testing-and-matched-therapy-in-hrher2-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-and-prognosis-of-breast-cancer-in-germline-iatmi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-differences-in-melanoma-survival-in-the-era-of-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-identification-of-patients-at-risk-for-moderate-to-severe-immunotherapy-related-adverse-events 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-angle-and-urea-to-creatinine-ratio-in-hospitalized-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-supportive-care-intervention-for-caregivers-of-head-and-neck-cancer-patients-a-qua 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guidance-conformance-of-mainstream-germline-cancer-testing-by-oncology-providers-in-the-veterans-hea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-in-symptomatic-metastatic-triple-negative-breast-cancer-treated-with-first-line-pembrol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-first-second-generation-egfr-tki-combination-therapy-versus-third-gene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-attitudes-and-factors-influencing-clinical-trial-participation-among-breast-cancer-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-timeliness-of-radiology-imaging-scheduling-at-a-comprehensive-cancer-center-a-quality-imp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-rivaroxaban-compared-with-lmwh-in-patients-with-cancer-associated-thrombosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-psa-at-diagnosis-correlate-with-decipher-score 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-observational-study-to-compare-the-efficacy-time-toxicity-and-cost-of-conventional-3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-of-first-line-amivantamab-plus-lazertinib-in-atypical-iegfr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opera-02-a-phase-3-study-of-palazestrant-plus-ribociclib-as-first-line-treatment-of-er-her2-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tissue-specific-programming-of-cd8-effector-t-cells-in-immune-checkpoint-inhibitor-associated-vitili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-rates-and-cure-modeling-with-dostarlimab-plus-chemotherapy-in-mismatch-repair-def 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-prediction-of-alisertib-induced-aurora-a-kinase-resistance-mutations-in-patients-with-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-lunbotinib-a400ep0031-a-next-generation-selective-ret-inhibitor-sri-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-results-from-the-phase-i-cervical-cancer-cohort-of-bat8008-a-trop-2-directed-antib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-clinical-and-genomic-analysis-of-mediastinal-germ-cell-tumors-gct-with-somatic-transfor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-basket-study-of-telisotuzumab-adizutecan-temab-a-abbv-400-a-c-met-protein-targeting-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-symptomatic-skeletal-events-sse-with-reduced-denosumab-dmab-dose-density-every-12 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonists-for-primary-prevention-of-breast-cancer-in-high-risk-women-a-real-world-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-from-nexus-01-a-phase-1-study-of-ly4052031-an-antibody-drug-conjugate-targeting-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-azvudine-fnc-in-phase-1-investigator-initiated-study-in-patients-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-and-time-toxicity-among-patients-with-cancer-enrolled-in-pharmacotherapy-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-tetravalent-death-receptor-5-dr5-agonist-ozekibart-inbrx-109-in-conventional-chondrosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-circulating-tumor-dna-and-tissue-biopsy-in-patients-with-newly-diagnosed-recurre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-fih-study-evaluating-the-safety-pharmacokinetics-and-efficacy-of-abbv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-multicenter-trial-of-chemoimmunotherapy-for-patients-with-neuroendocrine-or-aggressive-varia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-liver-we-share 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-cancers-of-unknown-primary-through-genomics-driven-clustering-a-pan-cancer-framework-for-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-real-time-artificial-intelligence-ultrasound-system-based-on-breast-density-in-c4-breast-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prognostic-prediction-model-for-neoadjuvant-chemotherapy-in-locally-advanced-breast-cancer-integra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intraductal-carcinoma-of-the-prostate-as-a-predictor-of-efficacy-of-olaparib-combined-with-novel-hor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-real-time-clinical-validation-of-a-novel-circulating-tumor-derived-blood-mrna-geneverify 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-the-efficacy-and-safety-of-oral-s-1-for-locally-advanced-or-recurrentmetastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-cost-and-complexity-in-tumor-informed-mrd-by-combining-patient-probe-panels-using-enspyre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-relapse-in-patients-with-stage-i-testicular-seminoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-car-t-cell-therapy-in-prostate-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-mapping-of-human-colorectal-cancer-cell-states-to-identify-co-targeting-opportunities-and-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacovigilance-signals-of-androgen-receptor-pathway-inhibitors-in-non-geriatric-men-with-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-and-treatment-patterns-of-lung-cancer-in-solid-organ-transplant-sot-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-doublet-versus-triplet-therapy-in-high-volume-metastatic-hormone-sensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-mortality-in-patients-with-advanced-non-small-cell-lung-cancer-ansclc-and-pd-l1-50-receiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-assessment-of-treatment-information-needs-in-an-advanced-prostate-cancer-online-support 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-hidden-struggle-mental-health-burden-among-oncology-physicians-globally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delivering-complex-pancreatic-cancer-care-locally-five-year-folfirinox-outcomes-from-northern-irela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ocular-toxicity-of-belantamab-mafodotin-based-combination-regimens-in-multiple-myeloma-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-stratified-outcomes-of-immune-checkpoint-inhibitors-in-geriatric-patients-with-melanoma-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-impact-of-a-digital-breast-cancer-survivorship-community-in-saudi-arabia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-with-or-after-chemoradiotherapy-crt-vs-crt-alone-in-limited-stage-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beta-blocker-use-at-immune-checkpoint-inhibitor-initiation-and-survival-in-advanced-solid-tumors-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-geospatial-visualization-to-inform-mobile-lung-cancer-screening-in-maryland 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-heparinoids-exposure-with-cytokine-release-syndrome-related-morbidity-and-mortality-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-renal-cell-carcinoma-a-population-based-real-world-study-of-incidence-prevalence-and-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-adoption-of-neoadjuvant-therapy-in-early-stage-resectable-non-small-cell-lung-cancer-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/respiratory-malignancies-among-patients-hospitalized-with-acute-respiratory-failure-nationwide-tren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-agent-versus-combination-paradigms-a-systematic-review-and-meta-analysis-of-the-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-evaluation-of-the-pan-immune-inflammation-value-piv-as-an-independent-prognostic-bioma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-stratification-for-prostate-cancer-screening-using-psa-and-prostate-volume 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-icarinhi-expression-and-clinical-ou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-genomic-subtype-on-intracranial-outcomes-in-treatment-naive-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-ierbb3i-alterations-in-5416-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/online-peer-support-for-breast-cancer-survivors-a-decentralized-multicenter-non-blinded-parallel-gr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sepsis-risk-factors-and-associated-mortality-in-elderly-mesothelioma-patients-with-malignant-pleural 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-convolution-attention-driven-vision-transformer-modeling-for-breast-cancer-detection-on-mamm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adebrelimab-in-combination-with-anlotinib-and-chemotherapy-as-neoadjuvant-therapy-for-resectable-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-window-of-opportunity-trial-of-intraperitoneal-intratumoral-lipopolysaccharide-in-periton 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trust-an-mri-based-ai-framework-for-non-invasive-prediction-of-treatment-response-and-prognosis-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-itop1i-alterations-on-outcomes-to-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-of-who-grade-ii-atypical-meningioma-using-the-aacr-project-genie-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rp2-oncolytic-immunotherapy-alone-and-in-combination-with-nivolumab-nivo-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-mortality-trends-from-pancreatic-cancer-and-associated-second-malignancies-in-the-us-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-silent-but-rising-threat-increasing-small-intestinal-cancer-mortality-among-older-adults-in-the-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atezolizumab-a-plus-pertuzumabtrastuzumabhyaluronidase-phesgo-in-patients-pts-with-solid-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-meta-10-19-an-il-10-expressing-anti-cd19-car-t-cell-product-in-patients-with-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-molecular-landscape-and-clinical-nomogram-of-pancreatic-cancers-harboring-dna-damage-repair-gene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cdc-analysis-of-pancreatic-cancer-and-diabetes-associated-pancreatic-cancer-mortality-among-older-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-mir-5193-to-predict-oxaliplatin-chemosensitivity-in-colorectal-cancer-integrated-in-sili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-composite-risk-score-for-chemotherapy-toxicity-and-unplanned-hospitalization-in-old 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-mechanisms-of-resistance-to-immune-checkpoint-inhibitors-icis-in-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-1-dose-escalation-study-of-the-oral-hif-2a-inhibitor-jmkx003948-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-an-ai-based-clinical-decision-support-system-for-guideline-concordant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-new-hla-genotyping-algorithm-to-show-accuracy-and-concordance-between-tumor-and-normal-samples 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-threshold-of-measurable-disease-in-al-amyloidosis-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-results-of-the-phase-2-study-of-silevertinib-bdtx-1535-in-treatment-naive-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-plus-anlotinib-and-chemotherapy-as-first-line-treatment-for-advanced-malignant-pleural-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bortezomib-plus-gemcitabine-cisplatin-versus-gemcitabine-cisplatin-as-first-line-treatment-for-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neoadjuvant-durvalumab-d-on-tumor-microenvironment-tme-features-and-their-association 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-mrna-sars-cov-2-vaccination-on-car-t-cell-therapy-outcomes-in-hematologic-malignancies-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vitamin-d-insufficiency-and-risk-of-taxane-induced-peripheral-neuropathy-results-from-swog-s1714 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-profound-study-a-large-scale-prospective-multicenter-case-control-trial-of-a-multi-cancer-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-symptom-signals-preceding-end-of-life-decline-in-outpatient-palliative-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/user-centered-design-of-a-copd-care-pathway-embedded-in-oncology-care-for-patients-receiving-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-iii-study-of-nivolumab-after-surgery-and-adjuvant-chemotherapy-in-nsclc-ecog-acrin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/change-in-relative-cerebral-blood-volume-as-a-biomarker-for-early-response-to-bevacizumab-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-pembrolizumab-among-patients-with-tmb-h-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-breast-cancer-case-volume-subtypes-and-age-at-diagnosis-in-vietnam-an-eight-ye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anthracycline-and-immunotherapy-free-neoadjuvant-chemotherapy-versus-keynote-522-regimen-in-early-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interstitial-lung-disease-as-a-predictor-of-inpatient-outcomes-among-patients-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-long-term-influence-of-adverse-social-determinants-of-health-on-clinical-outcomes-in-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-characterization-of-newly-diagnosed-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-pd-1-versus-pd-l1-inhibitors-in-metastatic-colorectal-cancer-a-real-world-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-swog-mentoring-advanced-practice-providers-mapp-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-pathologists-as-cancer-precision-medicine-leaders-the-florida-society-of-pathologists-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-met-overexpression-with-patient-outcomes-in-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leronlimab-in-combination-with-trifluridinetipiracil-tas-102-plus-bevacizumab-for-patients-with-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/downstream-mtor-effectors-and-vegfr-as-biomarkers-of-malignant-stratification-in-pathologic-and-geno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-colorectal-cancer-in-a-clinical-diagnostic-cohort-rasraf-alterations-micro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-early-endpoints-in-neoadjuvant-breast-cancer-to-support-accelerated-approval 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-intervention-in-disguise-an-immersive-care-model-for-families-where-a-parent-has-a-brain-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-first-line-pembrolizumab-plus-chemotherapy-in-patients-aged 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dexamethasone-reduction-or-omission-with-nepa-and-olanzapine-for-hec-a-phase-iii-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dinutuximab-beta-in-combination-with-chemotherapy-in-patients-with-refractory-or-relapsed-neuroblast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/four-cycles-of-tislelizumab-plus-gp-regimen-as-neoadjuvant-therapy-for-high-risk-t4n3-locally-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/major-adverse-cardiovascular-events-among-prostate-cancer-patients-in-the-va-stratified-by-hiv-stat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-imsh3i-loss-of-function-alterations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bulumtatug-fuvedotin-bfv-9mw2821-plus-toripalimab-in-perioperative-patients-with-muscle-invasive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soccer-a-randomized-phase-ii-trial-comparing-complete-clinical-response-after-short-course-radiatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-one-year-comparative-outcomes-of-quadruplet-and-triplet-induction-regimens-in-older-tran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-evaluation-of-a-novel-digital-pathology-image-analysis-pipeline-for-prediction-of-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-risk-stratification-for-distant-recurrence-in-node-positive-hrher2-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-epcoritamab-in-combination-with-rituximab-mini-cvp-for-older-unfitfrail-or-anthrac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-safety-of-lisocabtagene-maraleucel-liso-cel-in-patients-pt-with-second-line-or-late 2026-08-24 monthly 0.7 https://rjrindex.com/articles/local-and-state-paid-sick-leave-policies-and-timeliness-of-treatment-initiation-among-working-age-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-evolution-of-prostate-cancer-incidence-and-incidence-based-mortality-from-2000-to-2022-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-adebrelimab-combined-with-chemotherapy-in-locally-advanced-esophageal-squamous-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-precision-therapeutics-in-polycythemia-vera-insights-from-the-aacr-project-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-pilot-study-of-pembrolizumab-pem-and-neoadjuvant-radiation-therapy-nrt-in-high-risk-sof 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-plus-camrelizumab-followed-by-concurrent-chemoradiotherapy-for-unresectable-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-circulating-tumor-dna-and-local-tumor-regrowth-and-distant-metastasis-during-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-curatively-resected-dmmrmsi-h-colon-cancer-a-retrospective-analysis-of-a-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-mirogabalin-for-oxaliplatin-associated-chemotherapy-induced-peripheral-neuropathy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nalirifox-plus-targeted-therapy-as-first-line-treatment-for-metastatic-colorectal-cancer-a-phase-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-specific-mortality-in-invasive-lobular-versus-ductal-carcinoma-over-30-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-neighborhood-level-vulnerability-with-health-behavior-patterns-in-survivors-of-childh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gdf-15-in-oropharyngeal-squamous-cell-carcinoma-opscc-association-of-an-hpv-dependent-biomarker-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-spatial-profiling-for-identification-of-organ-specific-immune-features-in-the-peritumora 2026-08-24 monthly 0.7 https://rjrindex.com/articles/truce-11-an-open-label-single-arm-multicenter-phase-ii-study-of-tislelizumab-combined-with-nab-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-corticosteroid-use-and-outcomes-in-non-small-cell-lung-cancer-patients-receiving-immune-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-cardiac-related-deaths-crds-among-patients-pts-aged-65-years-with-b-cell-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-adjuvant-hepatic-arterial-infusion-chemotherapy-combined-with-donafenib-for-hepatocell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-of-tegavivint-a-tbl1-inhibitor-with-gemcitabine-in-patients-with-relapsed-or-refr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-immune-infiltrate-and-the-chromatin-3d-structure-of-gastric-tumors-from-mexi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-patient-centered-versus-disease-centered-language-in-public-facing-media-from-national-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/asc4kids-2-asciminib-in-pediatric-chronic-myeloid-leukemia-with-or-without-t315i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-neoadjuvant-tchp-in-her2-positive-non-metastatic-breast-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-breast-cancer-care-barriers-associated-with-treatment-delays 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-clinical-analysis-of-cervical-clear-cell-adenocarcinoma-a-real-world-multicenter-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-gastrointestinal-cancers-rural-urban-divide-and-cancer-site-disparities-in-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-antibody-drug-conjugate-regimens-without-concurrent-chemotherapy-versus-standard-chemoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-genomic-profiling-access-and-survival-outcomes-in-advanced-lung-aden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characterization-and-survival-of-patients-pts-with-ipik3cai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ha131-hepatic-arterial-infusion-in-combination-with-systemic-therapy-xelox-with-or-without-bevaci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-operative-intratumoral-toll-like-receptor-9-tlr9-agonist-vidutolimod-vidu-and-stereotactic-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mitochondrial-size-as-a-potential-factor-in-colorectal-cancer-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-continent-inter-laboratory-transfer-of-a-clinical-mass-spectrometry-lectin-magnetic-bead-assay 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kif11-as-a-druggable-target-in-nsclc-an-integrated-computational-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/3d-structural-revelations-of-neoadjuvant-hormonal-therapy-treatment-in-high-risk-localized-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-hypofractionated-versus-hypofractionated-radiotherapy-in-breast-cancer-real-world-toxicity-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-breast-cancer-diagnosis-in-rural-kenya-bridging-histopathological-gaps-toward-global-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-real-world-treatments-in-patients-with-metastatic-colorectal-cancer-mcrc-in-us-clinical-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpretable-machine-learning-for-overall-survival-prediction-in-vulvar-cancer-seer-based-developm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/territorial-oncology-laquila-asl1-abruzzo-italy-11-years-of-experience-in-a-complex-organization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-baseline-performance-status-on-survival-and-toxicity-with-ipilimumab-plus-nivolumab-a-10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-kit-and-pdgfra-molecular-landscape-and-outcomes-of-wild-type-gist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/green-tea-extractcatechin-supplementation-for-secondary-prevention-of-metachronous-colorectal-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-ct-derived-body-composition-and-colorectal-cancer-risk-a-group-based-trajectory-modeling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-attitude-and-practice-of-cardio-oncology-amongst-oncologists-and-cardiologists-of-south 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-of-surgical-patients-with-squamous-cell-carcinoma-of-unknown-primary-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/home-based-palliative-care-delivery-by-a-freelancing-palliative-care-specialist-to-terminally-ill-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-targeted-thromboprophylaxis-as-a-supportive-care-model-mapping-implementation-preferen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-peripheral-blood-absolute-lymphocyte-count-and-survival-outcomes-in-patients-with-pd-l1-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-for-co-occurring-colon-carcinoma-and-metabolic-syndrome-in-the-united-states-a-cdc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-from-malnutrition-and-gastrointestinal-cancer-in-us-adults-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metabolic-comorbidity-burden-and-oncologic-features-of-early-onset-colorectal-cancer-stratified-by-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kidney-function-trajectories-in-pediatric-acute-lymphoblastic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-practice-patterns-of-adjuvant-breast-hypofractionated-radiation-therapy-completion-in-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-persistent-opioid-use-following-curative-intent-radiation-for-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiologic-trends-and-risk-factor-transitions-in-adolescent-and-young-adult-lung-cancer-in-east-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-inpatient-outcomes-among-fda-approved-chimeric-antigen-receptor-t-cell-products-an-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-color-doppler-ultrasound-for-detecting-portal-venous-thrombosis-in-hepatocell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-clinical-study-of-the-efficacy-and-safety-of-adebrelimab-in-combination-with-lenvatinib-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-tp53-mutated-acute-myeloid-leukemia-at-a-single-institution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adebrelimab-combined-with-concurrent-chemoradiotherapy-as-neoadjuvant-therapy-for-locally-advanced-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-transplant-outcomes-stratified-by-induction-therapy-in-patients-with-aml-undergoing-allogeneic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colon-cancer-sidedness-in-relation-to-sepsis-risk-and-clinical-predictors-a-national-inpatient-samp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/symptom-monitoring-program-linked-to-electronic-referrals-sympler-a-single-arm-pilot-feasibility 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-leukemia-related-mortality-with-heart-failure-as-a-contributing-cause-among-us-adults-ag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discrimination-and-medical-trust-among-breast-cancer-outpatients-in-an-urban-safety-net-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-molecular-testing-among-patients-with-early-onset-metastatic-pancreatic-ductal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-being-aged-80-years-and-older-on-treatment-decision-making-discrepancies-in-cancer-care-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-long-acting-cisplatin-srgel-for-enhanced-chemoradiation-in-head-and-neck-cancer-preclinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-escalate-surgery-of-primary-lesions-after-neoadjuvant-immune-combination-therapy-in-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-disparities-in-latinx-communities-of-western-north-carolina-and-appalachia-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-cldn182-expression-in-gastric-and-gastroesophageal-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-and-cost-utilization-by-surgical-approach-for-elective-non-metastatic-colon-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-timely-antibiotic-administration-in-febrile-neutropenia-a-quality-improvement-initiative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-liver-cancer-related-mortality-in-adults-with-psychoactive-substance-use-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-effects-of-immune-checkpoint-inhibitors-in-locally-advanced-head-and-neck-squamous-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-identified-by-cost-facit-screening-in-a-community-oncology-population-a-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-demographics-and-cancer-incidence-projections-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interstitial-lung-disease-risk-and-outcomes-across-her2-targeted-therapies-commonly-used-in-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-and-survival-outcome-of-secondary-malignancies-in-waldenstrom-macroglobulinemia-wmlymphopl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whatsapp-based-behavioral-intervention-and-adherence-to-adjuvant-endocrine-therapy-in-early-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-dose-escalationexpansion-study-of-regn10597-anti-pd-1-il2ra-il2-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-first-in-human-trial-of-ag01-a-recombinant-humanized-monoclonal-antibody-to-progranulingly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-breast-cancer-screening-insights-from-an-adult-female-outpatient-population-in-the-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cost-effectiveness-analysis-of-jak-inhibitor-therapy-versus-allogeneic-stem-cell-transplantation-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-co33battman-trial-a-phase-3-randomized-study-of-botensilimab-balstilimab-versus-best-suppor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sonesitatug-vedotin-sone-ve-monotherapy-in-patients-pts-with-claudin-182-positive-cldn182-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-time-liquid-biopsy-guided-assessment-of-radiation-response-longitudinal-circulating-free-dna-k 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-multi-omics-profiling-of-pulmonary-signet-ring-cell-adenocarcinoma-to-reveal-diagnostic-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-quality-cancer-survivorship-care-competencies-for-primary-care-a-modified-delphi-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-from-3d-predict-glioma-chemosensitivity-testing-of-primary-cns-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-microbiota-in-response-to-treatment-in-anal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncovering-prostate-cancer-and-sepsis-related-mortality-shifts-in-the-usa-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bms-986504-in-patients-pts-with-advanced-solid-tumors-with-homozygous-imtap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-lenvatinib-versus-dabrafenib-plus-trametinib-dt-in-ibrafi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-3-month-enzalutamide-monotherapy-in-biochemically-recurrent-prostate-cancer-bcr-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-informed-molecular-monitoring-using-patient-specific-pcr-assays-and-oncologist-decision-suppor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-toxicity-of-durvalumab-after-chemoradiation-in-stage-iii-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-rechallenge-in-extensive-stage-small-cell-lung-cancer-a-real-world-retrospective-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ablation-of-oligo-residual-disease-to-prolong-progression-free-survival-in-ieg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/capsule-networks-for-cancer-imaging-applications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-plus-chemotherapy-versus-chemotherapy-alone-as-first-line-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-phlebotomy-phl-burden-and-treatment-gaps-in-us-patients-with-polycythemia-vera-a-chart 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-survival-of-patients-with-cancer-associated-thrombosis-experience-from-a-tertiary-hos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-of-musculoskeletal-and-rheumatologic-msk-r-immune-related-adverse-events-iraes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-genomic-and-transcriptomic-profiling-of-driver-pathway-relationships-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-projections-of-cancer-and-depression-mortality-in-the-united-states-through-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-profiling-of-early-onset-colorectal-cancer-in-an-irish-tertiary-cancer-centre-outcomes-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-with-or-without-radiation-versus-upfront-esophagectomy-in-small-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-to-rescue-following-colorectal-cancer-surgery-at-minority-serving-hospitals-a-national-inpa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-scale-assessment-of-chatgpt-performance-in-medical-oncology-clinical-decision-making 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prism-a-transparent-self-correcting-llm-system-for-reproducible-therapy-recommendations-in-neuroen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-disability-adjusted-life-years-daly-from-colorectal-cancer-in-germany-a-lesson-to-be-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-nirogacestat-compared-to-prior-standard-of-care-soc-systemic-agents-in-desm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-healthcare-delivery-model-with-stage-at-diagnosis-of-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-early-intracranial-hemorrhage-on-survival-and-critical-care-utilization-in-acute-promyeloc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-trastuzumab-plus-chemotherapy-in-her2-positive-biliary-tract-cancers-from-a-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histology-and-stage-specific-incidence-trends-in-appendiceal-adenocarcinoma-in-the-united-states-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-pathological-complete-response-based-on-multi-time-point-sup18sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-lung-cancer-in-lung-cancer-survivors-clinical-characterization-and-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-androgen-receptor-ar-in-breast-cancer-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triple-m-syndrome-following-immune-checkpoint-inhibitors-clinical-features-and-mortality-drivers-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-immune-gene-signatures-to-inform-clinical-course-of-patients-with-metastatic-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-single-center-observational-clinical-study-on-envafolimab-pd-l1-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-with-platinum-pemetrexed-chemotherapy-versus-ipilimumab-nivolumab-in-per 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-and-demographic-disparities-in-breast-cancer-deaths-with-co-existing-diabetes-melli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-real-world-outcomes-from-late-line-chemotherapy-for-advanced-colorectal-cancer-a-population-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-metastasis-in-chondroblastoma-an-institutional-cohort-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-for-advanced-gastric-cancer-experience-from-uzbekistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiation-therapy-utilization-and-survival-associations-in-metastatic-merkel-cell-carcinoma-in-the-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adult-failure-to-thrive-aftt-on-inpatient-mortality-im-and-resource-utilization-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-profiling-of-tumor-infiltrating-lymphocytes-in-patients-with-primary-and-metastatic-soft-tiss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-accuracy-and-clinical-utility-of-an-algorithm-based-petct-service-for-quantifying-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-and-head-and-neck-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-in-metastatic-triple-negative-breast-cancer-a-national-cancer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adoption-of-bayesian-optimal-interval-boin-design-in-phase-i-oncology-trials-trends-and-challeng 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-op-35-classification-of-potentially-avoidable-hospital-visits-after-chemotherapy-using-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-anemia-on-real-world-outcomes-in-myelofibrosis-a-propensity-matched-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcome-of-low-frequency-outpatient-monitoring-for-venetoclax-initiation-in-cll-single-c-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/segment-level-molecular-characterization-of-the-proximal-colon-in-tcga-colon-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-trends-in-hodgkins-lymphoma-incidence-in-the-united-states-and-puerto-rico-1999-to-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-toxicity-of-second-generation-tkis-versus-imatinib-in-first-line-chronic-myeloid-leuk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-time-to-event-detection-of-immune-related-adverse-events-from-electronic-health-records-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-bayesian-approach-for-assessing-associations-between-ecog-performance-status-ecog-ps-and-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-multi-center-open-label-study-to-evaluate-the-safety-tolerability-pharmacokinetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-assessment-of-implementing-evidence-based-de-escalation-strategies-in-early-breast-cancer-man 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-guidelines-and-interoperability-mcode-stu4-coverage-of-nccn-breast-cancer-decision-criteri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-engineered-probiotic-expressing-foma-targeted-antimicrobial-peptides-on-intestinal-tumorig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-disciplinary-discharge-coordination-team-to-overcome-discharge-barriers-and-address-the-risk-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pillar-of-safety-standardizing-oral-chemotherapy-protocols 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incorporating-tumor-pathological-subtype-into-a-multiparameter-model-improved-accuracy-in-predictin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-use-without-approval-patterns-biases-and-biomarkers-in-patients-with-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-dermatologic-surveillance-in-solid-organ-transplant-recipients-through-a-navigation-progra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-distribution-treatment-patterns-and-stage-specific-survival-in-merkel-cell-carcinoma-before 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-1a-study-of-lp-184-a-tumor-site-activated-novel-alkylating-agent-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/double-lung-transplantation-in-patients-with-recent-history-of-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-circulating-tumor-dna-ctdna-test-uptake-among-diverse-cancer-patients-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-complete-crc-screening-initiative-increasing-colonoscopy-completion-after-positive-stool-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lost-in-the-referral-loop-improving-completion-of-cancer-genetics-referrals-through-targeted-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-factors-associated-with-chemotherapy-induced-anemia-in-early-and-locally-advanced-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiologic-and-clinicopathological-characteristics-of-smarca4-deficient-non-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clear-access-barriers-and-facilitators-to-accessing-symptom-support-among-culturally-and-linguistic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-implementation-of-a-lung-cancer-screening-program-in-a-safety-net-health-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-insurance-status-on-disease-severity-and-care-utilization-in-hospitalized-melanoma-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-of-mortalities-in-ovarian-carcinoma-and-hypertension-comorbidity-related-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-profiles-of-cdk46-inhibitor-in-patients-with-hormone-receptor-positive-and-huma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mitochondrial-apoptosis-markers-in-the-progression-of-endometrioid-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-metastatic-melanoma-in-colombia-a-retrospective-cohort-study-from-the-remmec-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-multiplexed-functional-profiling-to-reveal-antiproliferative-activity-of-parp-inhibitors-miss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparative-socio-ecological-analysis-of-psychosocial-barriers-to-breast-and-cervical-cancer-scree 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-cavity-and-oropharyngeal-cancer-incidence-5-year-survival-vs-air-pollution-levels-across-new 2026-08-24 monthly 0.7 https://rjrindex.com/articles/apatinib-combined-with-adebrelimab-and-gemox-regimen-as-first-line-treatment-for-advanced-intrahepat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenetic-ctdna-kinetics-as-a-predictor-of-early-progression-in-advanced-egej-cancers-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alpha-fetoprotein-as-a-biomarker-of-response-to-first-line-chemoimmunotherapy-in-metastatic-hepatoce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-non-hodgkin-lymphoma-incidence-in-the-car-t-era-a-population-based-analysis-usin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-neoadjuvant-immunochemotherapy-versus-chemoradiotherapy-in-resectable-esopha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mpower-a-pilot-trial-among-men-with-prostate-cancer-optimizing-wellness-by-enhanced-relief-from-hot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blind-placebo-controlled-trial-of-antiviral-prophylaxis-and-oral 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-durvalumab-or-tislelizumab-combined-with-s-1-for-resected-high-risk-biliary-tract-cancers-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarc045-a-phase-2-trial-of-tebentafusp-in-hla-a0201-positive-patients-with-advanced-clear-cell-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-of-patients-with-cholangiocarcinoma-receiving-chemotherapy-versus-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-sup177sup-lulu-dota-tate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synergy-a-phase-1b2-study-of-nenocorilant-a-selective-glucocorticoid-receptor-antagonist-plus-ni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-trial-comparing-temozolomide-with-pcv-as-adjuvant-chemotherapy-in-grade-2-and-3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup212sup-pb-pb-mp0712-in-patients-with-small-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-donafenib-combined-with-pd-1-inhibitors-and-transarterial-chemoembolization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/yield-and-clinical-utility-of-peritoneal-cytology-in-patients-with-locally-advanced-gallbladder-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/solar-a-post-approval-study-evaluating-longitudinal-performance-of-a-blood-based-test-for-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variation-in-metastatic-colorectal-cancer-mcrc-patient-survival-among-different-oncology-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphoma-epidemiology-in-syria-a-2024-analysis-from-the-nations-primary-oncology-referral-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-patient-self-reported-adherence-to-btkis-and-symptoms-in-cllsll-using-an-electronic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomized-trial-of-pembrolizumab-in-combination-with-sacituzumab-govitecan-vs-standard 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-preservation-strategy-using-dostarlimab-for-dmmrmsi-h-resectable-solid-tumors-with-whole-geno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-study-of-revumenib-plus-venetoclaxazacitidine-in-adults-with-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rocket-cll-a-randomized-open-label-multicenter-phase-3-study-of-rocbrutinib-lp-168-versus-pirt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alliance-a072301-a-phase-iii-trial-of-radiotherapy-followed-by-adjuvant-temozolomide-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gamma-knife-radiosurgery-for-brain-metastases-in-the-era-of-modern-systemic-therapy-a-prospective-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-of-tislelizumab-in-combination-with-gemcitabine-and-nab-paclitaxel-and-chemoresist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-analysis-of-pd-1-receptor-occupancy-in-spleen-and-tumor-infiltrating-lymphocytes-in-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-brain-metastases-as-a-prognostic-factor-in-extensive-stage-small-cell-lung-cancer-treated-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-vemurafenib-with-cobimetinib-in-ibrafi-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-versus-upfront-surgery-for-resectableborderline-resectable-pancreatic-ductal-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-komet-nct04924608-a-phase-3-study-of-selumetinib-in-adults-with-nf1-pn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-dose-chemotherapy-hdct-and-peripheral-blood-stem-cell-transplant-pbsct-for-relapsed-seminom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fezolinetant-for-the-management-of-vasomotor-symptoms-in-patients-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-tki-therapy-following-first-line-immune-checkpoint-inhibitor-combinations-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exosome-whisperers-decoding-sphk1s-role-in-cisplatin-induced-immune-escape-of-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-olaparib-in-combination-with-pembrolizumab-in-metastatic-uveal-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-as-a-biomarker-for-pathologic-response-and-clinical-outcomes-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-mirna-expression-as-a-potential-biomarker-of-immune-related-toxicity-in-patients-with-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-changes-in-prostest-a-blood-based-mrna-assay-as-a-predictor-of-outcomes-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hpv-enriched-oropharyngeal-head-and-neck-cancer-and-inpatient-outcomes-a-national-analysis-of-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benchmarking-histology-foundation-models-to-identify-prosigna-high-risk-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-prevention-of-acute-leukemias-in-high-risk-patients-the-therapeutic-promise-of-glp-1-recept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-to-define-molecular-drivers-of-colorectal-neuroendocrine-carcinoma-subtypes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/astron-ogsg-2401-a-multicenter-prospective-trial-of-ferric-carboxymaltose-without-erythropoiesis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imarix-for-primary-and-secondary-central-nervous-system-lymphomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-single-arm-study-of-romiplostim-n01-for-cancer-treatment-induced-thrombocytopenia-in-leu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-pivotal-study-of-savolitinib-in-patients-with-imeti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-genetic-correlates-in-metastatic-hormone-sensitive-prostate-cancer-mhspc-treated-with-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-of-burkitt-lymphoma-in-adults-novel-molecular-insights-and-implications-for-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-upper-endoscopy-use-prior-to-gastric-cancer-diagnosis-among-high-risk-populations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-fruquintinib-f-plus-sintilimab-s-versus-axitinib-a-or-everolimus-e-by-scores-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cabozantinib-plus-nivolumab-cn-versus-sunitinib-s-in-patients-with-advanced-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/closing-the-distance-and-the-specialist-nursing-optimal-placement-tool-sn-opt-strategic-placement 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-associated-macrophage-tam-score-as-an-independent-predictor-of-recurrence-in-residual-diseas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pthrp-associated-gene-programs-in-cancer-cachexia-and-hypercalcemia-and-therapeutic-targeting-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-multiomic-profiling-to-identify-de-differentiated-tumor-phenotypes-and-exhausted-t-cell-nich 2026-08-24 monthly 0.7 https://rjrindex.com/articles/admission-acuity-and-inpatient-outcomes-across-major-gastrointestinal-malignancies-in-the-united-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-based-differences-in-metastasis-among-patients-with-early-onset-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-renal-adverse-events-re-ae-and-electrolyte-changes-with-immunotherapy-it-in-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-v-blocker-selectivity-with-survival-and-immune-related-outcomes-in-melanoma-and-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rad2nivo-phase-ib-study-of-radium-223-rad-with-nivolumab-nivo-in-patients-pts-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-rna-and-dna-ngs-testing-for-the-detection-of-clinically-relevant-fusions-in-pediatric-so 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rapid-digital-patient-derived-organoid-testing-for-guiding-therapy-in-patients-with-metastatic-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itp53i-status-and-licensing-complexifngh-transcriptional-profiles-to-strati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-vebreltinib-in-advanced-clear-cell-sarcoma-vebrant-a-multicenter-phase-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-multidimensional-cfdna-assay-for-cancer-detection-and-tissue-of-orig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-enzalutamide-enza-in-patients-pts-with-metastatic-hormone-sensitive-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-eganelisib-in-adults-with-higher-risk-myelodysplastic-syndrome-hr-mds-or-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/c-post-study-of-adjuvant-cemiplimab-for-high-risk-cutaneous-squamous-cell-carcinoma-cscc-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-hampe-plasma-cell-to-predict-pathological-complete-response-in-io-treated-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-of-a-pediatric-precision-oncology-protocol-utilizing-paired-somatic-and-germli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neurological-immune-related-adverse-events-and-overall-survival-in-patients-with-advanced-solid-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-chronic-and-metabolic-morbidity-among-survivors-of-childhood-acute-lymphoblastic-leukemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-durvalumab-d-in-patients-pts-with-previously-untreated-her2-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-mitomycin-c-plus-carboplatin-followed-by-paclitaxel-vs-standard-doxorubicin-cyclophosph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-neoadjuvant-immunotherapy-plus-chemotherapy-in-borrmann-type-iv-gastric-cancer-periscope-01-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-safety-outcomes-of-pregnancy-among-young-breast-cancer-survivors-results-from-a-prospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-multicenter-first-in-human-fih-global-study-of-sim0505-an-anti-cdh6-cdh6-antibody-dru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-repair-hrr-genes-and-overall-survival-prognosis-within-the-stratos-p-clas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opportunities-for-breast-cancer-prevention-among-pediatric-lymphoma-survivors-treated-with-chest-rad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatially-organized-immune-niches-in-high-grade-primary-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/yttrium-90-sirt-followed-by-lenvatinib-plus-sintilimab-for-unresectable-intermediate-to-advanced-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-dr4dr5-agonist-aponermin-monotherapy-in-advanced-chondrosarcoma-preliminary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/embedding-germline-genetic-testing-into-african-oncology-care-early-results-from-the-genetic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-distribution-of-cancer-treatment-trials-and-population-level-cancer-outcomes-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scale-2-a-phase-2-trial-evaluating-neoadjuvant-short-course-radiotherapy-combined-with-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-os-in-premenopausal-erpr-her2-breast-cancer-bc-treated-with-endocrine-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-stratified-late-outcomes-following-bispecific-antibody-therapy-in-multiple-myeloma-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-effectiveness-and-safety-of-lurbinectedin-lurbi-for-previously-treated-extensive-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-plus-immune-checkpoint-inhibitors-with-or-without-oral-fluorouracil-chemotherapy-drugs-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-neutrophil-to-lymphocyte-ratio-and-thrombotic-events-in-us-veterans-with-polycythemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-lb-100-plus-doxorubicin-as-first-line-of-advanced-soft-tissue-sarcomas-a-spanish-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-during-pregnancy-and-child-health-perspectives-evidence-from-real-world-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cdh17-expression-and-tumor-microenvironment-composition-in-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-in-rare-histologic-subtypes-of-early-stage-triple-negative-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-trial-of-trifluridinetipiracil-ftdtpi-plus-ramucirumab-ram-versus-ftdtpi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sglt2-inhibitors-on-clinical-outcomes-in-diabetic-patients-with-cll-receiving-btk-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/butaselen-combined-with-radiotherapy-for-newly-diagnosed-h3k27m-mutant-spinal-diffuse-midline-glioma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-estrogen-receptor-er-degraders-compared-to-standard-endocrine-therapy-et-in-er-positive-hu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-biosimilar-bevacizumab-adoption-and-medicare-spending-by-socioeconomic-deprivation-and-rur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-on-treatment-plasma-microrna-profiling-for-identification-of-biomarker-signatures-assoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-randomized-trial-of-radiotherapy-with-pembrolizumab-vs-cisplatin-for-unfavorable-risk-p16 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-single-arm-trial-of-adebrelimab-plus-nab-paclitaxel-and-carboplatin-as-first-line-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-drug-drug-interactions-and-progression-free-survival-in-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tsy-310-a-novel-bispecific-egfrror1-adc-assessment-of-antitumor-activity-in-heterogeneous-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-infection-related-mortality-among-older-adults-with-multiple-myeloma-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-real-world-adoption-of-5-fraction-breast-radiotherapy-in-the-united-states-2020-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-estrogen-and-progesterone-receptor-expression-disparity-in-early-stage-hrher2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-from-diagnosis-to-treatment-in-multiple-myeloma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/depth-and-durability-of-response-with-tgf-v-trapping-in-recurrent-or-metastatic-rm-hpv-negative-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-single-center-phase-ii-trial-of-mitoxantrone-hydrochloride-liposome-combined-with-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-the-biomarker-directed-randomized-phase-2-keynote-495keyimpact-study-of-pembrol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-a-highly-sensitive-tumor-informed-illumina-whole-genome-sequencing-research-assay-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-tarlatamab-in-small-cell-lung-cancer-sclc-and-extrapulmonary-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/limb-compression-therapy-and-chemotherapy-induced-peripheral-neuropathy-in-women-with-gynecologic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-internal-validation-of-a-clinical-prognostic-model-for-smarcb1-deficient-renal-medul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-variation-in-pain-medication-prescriptions-among-breast-prostate-and-pancreatic-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-chemotherapy-with-ag-regimen-with-or-without-nimotuzumab-in-borde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-infiltrating-lymphocytes-lm103-infusion-in-solid-tumors-a-phase-i-trial-evaluating-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-multi-center-phase-ibii-trial-of-first-line-cadonilimab-plus-axitinib-in-advanced-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-associated-differences-in-osimertinib-pharmacokinetics-among-asian-patients-with-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/puxitatug-samrotecan-azd8205-vs-chemotherapy-in-patients-with-b7-h4-selected-advancedmetastatic-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-trial-of-bh-30643-a-novel-macrocyclic-non-covalent-mutant-selective-omni-egfr-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nsabp-fc-13-empire-a-phase-ii-platform-study-of-cemiplimab-monotherapy-or-cemiplimab-based-combin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-concomitant-glp-1-receptor-agonist-use-on-overall-survival-and-chemotherapy-related-advers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-with-bria-imt-cpi-in-advanced-metastatic-breast-cancer-at-12-and-24-months 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phenotypic-heterogeneity-in-primary-tumors-and-brain-metastases-of-small-cell-lung-cancer-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-dependent-pathogenic-variant-risk-in-female-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-and-incidence-of-brain-metastases-in-high-grade-neuroendocrine-carcinomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrs-8080-an-oral-selective-estrogen-receptor-degrader-serd-in-erher2-advanced-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-a-simple-pre-mobilization-complete-blood-count-predict-stem-cell-yield-low-cost-predictors-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-depression-anxiety-suicidality-substance-use-and-palliative-care-use-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-vitamin-d-deficiency-with-risk-in-multiple-myeloma-a-real-world-cohort-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-clinical-and-economic-signatures-of-car-t-cell-therapy-in-multiple-myeloma-across-demog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrathecal-it-therapy-associated-pseudoprogression-psp-in-leptomeningeal-metastases-lm-from-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-177lulu-psma-617-versus-radium-223-in-bone-metastatic-castration-resistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-olomorasib-pembrolizumab-in-patients-with-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-of-stereotactic-radiosurgery-quality-across-the-community 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anal-cancer-incidence-among-medicaid-enrollees-with-hiv-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/more-than-follow-up-outcomes-from-an-integrated-cancer-survivorship-wellness-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-lung-cancer-in-patients-with-respiratory-tract-infections-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-blood-liquid-biopsy-in-nipple-discharge-for-decoding-tumor-derived-cnv-signatures-for-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onvansertib-plus-standard-of-care-chemotherapy-plus-bevacizumab-in-first-line-ras-mutated-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-golidocitinib-a-jak1-inhibitor-with-anti-pd-1-antibody-to-improve-tumor-response-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-efficacy-of-trastuzumab-deruxtecan-t-dxd-in-her2-positive-and-her2-low-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-pathophysiology-to-prognosis-an-oncology-curriculum-for-interdisciplinary-palliative-care-spec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imacrod2i-and-icdkn2ai-in-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-limitations-of-artificial-intelligence-ai-in-radiologic-tumor-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-lung-cancer-stage-at-diagnosis-and-pre-treatment-staging-in-united-states-2004-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd40-agonist-mitazalimab-mfolfirinox-mffx-in-patients-with-metastatic-pancreatic-ductal-adenocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/functional-binding-of-pd-1-ligands-overcoming-pd-l1-staining-limitations-to-predict-therapy-respons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncogenic-egfr-amplification-in-egfr-mutated-nsclc-egfr-subtype-dependent-association-with-benefit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-melanoma-skin-cancer-related-mortality-in-the-united-states-a-25-year-cdc-wonder-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/main-cav-phase-iii-randomized-trial-of-maintenance-cabozantinib-and-avelumab-versus-avelumab-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoimmunotherapy-for-large-cell-neuroendocrine-carcinoma-lcnec-of-the-lung-a-multi-institutiona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-remote-symptom-monitoring-on-acute-care-utilization-in-phase-i-cancer-patients-secondary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/platinum-re-challenge-in-platinum-resistant-ovarian-cancer-real-world-patterns-and-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjunctive-and-post-transplant-doxycycline-in-systemic-light-chain-al-amyloidosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-first-line-1l-platinum-based-chemotherapy-pbc-and-avelumab-1l-maintenance-in-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-mortality-trends-in-acute-versus-chronic-myeloid-leukemia-in-the-us-popula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-we-be-one-step-ahead-a-systematic-review-and-meta-analysis-on-the-clinical-prowess-of-artifici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-yield-and-utility-of-germline-multigene-panel-testing-across-hereditary-cancer-syndromes-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-symptom-monitoring-using-careology-at-guys-and-st-thomas-nhs-foundation-trust-gstft 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-stratified-risk-of-second-malignancies-in-hodgkin-lymphoma-survivors-a-retrospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-gabapentinoid-exposure-and-chemotherapy-associated-peripheral-neuropathy-among-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-analysis-of-adolescent-and-young-adult-patients-with-hairy-cell-leukemia-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-testing-in-endometrial-cancer-genec-a-study-on-the-patient-experience-with-msk-impact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rock-2-an-ongoing-open-label-randomized-multicenter-phase-2-study-of-rocbrutinib-versus-investiga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-hodgkin-lymphoma-and-diabetes-related-mortality-in-the-united-states-1999-2023-a-cdc-wonder-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-hetrombopag-for-secondary-prevention-of-chemotherapy-induced-thrombocytopenia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-ascos-pga-at-an-nci-designated-comprehensive-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-2022-nccn-guideline-update-on-germline-testing-in-early-onset-colorectal-cancer-insig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-spatial-inequities-in-us-county-level-breast-cancer-mortality-2018-2023-a-baye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-analysis-of-dyslipidemia-and-attributable-risk-in-lorlatinib-treated-alk-positive-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-real-world-genomic-data-to-characterize-immunotherapy-response-in-cancers-with-germline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-polatuzumab-vedotin-plus-r-chp-versus-r-chop-in-newly-diagnosed-diffuse-large 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-afp-liver-reserve-discordance-and-microvascular-invasion-in-resected-and-transplanted-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/divergence-between-regulatory-approvals-and-guideline-recommendations-in-multiple-myeloma-helping-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-operative-lymph-node-staging-in-localized-esophageal-cancer-using-a-high-sensitivity-ctdna-assay 2026-08-24 monthly 0.7 https://rjrindex.com/articles/critical-survivorship-challenges-among-breast-cancer-survivors-in-a-low-and-middle-income-country 2026-08-24 monthly 0.7 https://rjrindex.com/articles/specialist-referral-patterns-and-relationship-to-outcomes-in-patients-with-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-in-gastric-and-gastroesophageal-adenocarcinoma-context-dependent-survi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-cirrhosis-on-the-metabolic-profile-tumor-presentation-and-management-of-masld-associated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/node-sparing-modified-short-course-radiotherapy-combined-with-capecitabine-and-pd-1ctla-4-for-mss-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/duration-to-treatment-interval-and-survival-outcomes-in-aggressive-lymphoma-a-us-academic-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immunonutrition-in-patients-undergoing-hepatectomies-for-liver-tumors-a-randomized-contro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-biomarkers-predicting-sensitivity-to-atezolizumab-plus-bevacizumab-in-resected-hepatocellula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adverse-social-determinants-of-health-on-long-term-mortality-and-comorbidities-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-mortality-from-gastric-cancer-with-metastatic-involvement-of-the-digestive-and-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-incidence-and-disability-adjusted-life-years-of-laryngeal-cancer-in-pakistan-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-atezolizumab-with-bevacizumab-ab-for-hepatocellular-carcinoma-hcc-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-disparities-in-outcomes-among-hospitalizations-for-myelodysplastic-syndromes-complicated-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-health-information-seeking-and-digital-health-engagement-in-adults-with-cardiovascular-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-institution-clinical-outcomes-with-pembrolizumab-plus-neoadjuvant-radiation-sarc032-regimen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-of-day-of-liver-transplant-reperfusion-as-a-predictor-of-disease-free-and-overall-survival-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-radiotherapy-and-risk-of-wound-healing-following-ommaya-reservoir-placement-in-leptomeningeal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-map-s1800e-a-randomized-phase-iiiii-study-of-docetaxel-and-ramucirumab-with-or-without-cemipl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1a1b-study-of-the-safety-pharmacokinetics-and-antitumor-activity-of-ziftomenib-in-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-first-in-human-study-of-th9619-in-patients-with-advanced-refractory-solid-tumors-odin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-onset-increases-in-neutrophil-to-lymphocyte-ratio-as-an-identifier-of-mild-and-severe-immune-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-kras-variant-subtypes-with-survival-and-recurrence-in-patients-with-surgically-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/litespark-033-phase-3-study-of-belzutifan-plus-zanzalintinib-versus-cabozantinib-for-recurrent-clea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-correlation-and-causal-associations-between-metabolic-traits-and-lung-cancer-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-disparities-in-prostate-cancer-mortality-in-the-african-union-a-retrospective-analysis-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-trial-of-radium-223-dichloride-and-cabozantinib-in-patients-pts-with-renal-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-real-world-outcomes-of-tarlatamab-and-lurbinectedin-in-relapsed-extensive-stage-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalation-and-expansion-study-of-afn0328-a-novel-mrna-based-immunotherapy-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-co-designed-nurse-led-geriatric-oncology-multidisciplinary-model-in-treatment-naive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-double-blind-phase-3-trial-of-the-fixed-dose-combination-fosrolapitantpalonosetron-hr2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sms-message-sentiment-as-a-predictive-indicator-of-quality-of-life-and-program-adherence-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-patterns-and-disparities-in-primary-malignant-brain-neoplasms-among-us-adults-aged-75-y 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-rosai-dorfman-disease-systematic-review-of-published-case-reports-and-small-series-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-adjuvant-immune-checkpoint-inhibitors-in-resected-renal-cell-carcinoma-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-beyond-progression-after-early-radiographic-changes-on-first-line-ipilimumabnivolumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/platinum-sensitive-relapsed-sclc-what-is-the-best-option-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-a-blood-based-multimodal-immune-response-score-in-a-real-world-cohort-of-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoray-phase-iia-results-a-study-of-sup177sup-lulu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-transcriptional-regulation-of-cisplatin-sensitivity-in-small-cell-lung-cancer-using-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-eligibility-for-adjuvant-cdk46-therapy-in-hrher2-early-breast-cancer-a-comparative-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptome-wide-profiling-of-antibody-drug-conjugate-adc-targets-across-solid-tumors-with-ihc-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-biomarkers-for-pfs-in-patients-receiving-quaratusugene-ozeplasmid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-clinical-significance-of-ar-v7-in-extra-prostatic-malignancies-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/routine-targeted-ngs-testing-to-guide-treatment-decisions-in-all-stage-nsclc-public-hospital-implem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-survival-outcomes-in-stage-iii-cervical-cancer-patients-receiving-definitive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-quality-of-life-and-decision-regret-in-patients-undergoing-laryngectomy-procedure 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-self-efficacy-self-care-and-health-related-quality-of-life-in-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liver-transplantation-for-unresectable-colorectal-liver-metastases-a-systematic-review-and-meta-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-screening-and-site-specific-mortality-in-adults-aged-65-years-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-study-on-the-effect-of-parpi-as-maintenance-therapy-on-recurrent-site-after-first-line-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-liver-metastases-at-diagnosis-among-young-adults-with-colorectal-cancer-a-seer-based-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-uveal-melanoma-surveillance-and-related-outcomes-in-the-immunotherapy-era-in-a-rural-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-ctdna-testing-in-metastatic-breast-cancer-patients-with-no-radiological-evi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-gastric-cancer-risk-before-cancer-suspicion-ihelicobacter-pylori 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-and-prognostic-factors-of-breast-cancer-brain-metastases-patients-based-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-blockade-icb-in-advancedmetastatic-leiomyosarcoma-lms-real-world-cohort-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/challenges-and-strategies-for-multidisciplinary-care-of-ocular-adverse-events-real-world-perspectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adenoma-detection-following-screening-colonoscopy-and-stool-based-colorectal-cancer-screening-tests 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actinic-keratosis-as-a-premalignant-lesion-systematic-review-and-meta-analysis-of-topical-field-dir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-female-breast-cancer-incidence-and-mortality-in-adolescents-and-young-adults-in-sub-sahara 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-datopotamab-deruxtecan-after-trastuzumab-deruxtecan-in-metastatic-hormone-receptor-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-audit-of-initial-experience-of-stereotactic-body-radiotherapy-for-extracranial-oligometastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-and-survival-outcomes-in-colorectal-cancer-in-egypt-implications-for-precision 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-death-according-to-the-peaceful-end-of-life-theory-in-a-hospice-in-southern-brazil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-profiling-of-salivary-gland-cancers-a-single-institution-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ncdb-analysis-of-follicular-adenocarcinoma-well-differentiated-demographic-and-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-engagement-advance-care-planning-and-healthcare-utilization-in-hepatobiliary-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-risk-reducing-interventions-among-breast-cancer-patients-with-pathogenic-germline-var 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-oncology-documentation-exchange-through-intelligent-automation-operational-outcomes-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-anatomical-subsite-matter-in-acral-melanoma-a-cohort-study-of-clinical-and-molecular-features 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-mortality-trends-of-cervical-cancer-among-younger-and-middle-aged-women-in-the-united-stat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-true-cost-of-infusion-care-comparing-hospital-chargemaster-cash-and-negotiated-pric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-associations-of-p16-expression-high-risk-hpv-genotypes-and-tumor-infiltrating 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-colonoscopy-outcomes-a-systematic-review-and-meta-analysis-of-randomized-controlled-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-cost-of-cancer-care-in-singapore-a-population-based-analysis-of-healthcare-expenditures-and-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-clinical-and-treatment-characteristics-on-fear-of-cancer-recurrence-and-quality-of-life-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/operationalizing-bispecific-antibody-therapy-in-community-oncology-capturing-insights-on-clinician 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-novo-vs-recurrent-metastatic-presentation-and-outcomes-with-first-line-egfr-tki-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-surveillance-modalities-and-biopsy-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-progression-survival-and-psychosocial-burden-in-early-stage-breast-cancer-a-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cardiomyopathy-associated-mortality-among-breast-cancer-adults-aged-45-ye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-intraperitoneal-fast-manufactured-il-9-secreting-ceacam5-targeted-car-t-cells-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-whole-exome-sequencing-and-single-nucleus-rna-sequencing-to-identify-actionable-alter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myxoidround-cell-liposarcoma-misdiagnosis-incidence-etiology-and-importance-of-ny-eso-1-testing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biology-informed-predictive-modeling-and-resistance-monitoring-in-trastuzumab-deruxtecan-treated-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-tislelizumab-plus-chemotherapy-in-msspmmr-high-risk-locally-advanced-colon-cancer-upda 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequence-of-similar-payload-adcs-does-it-make-sense-in-real-world-her2-low-advanced-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vista-targeted-combination-immunotherapy-for-suppression-of-breast-cancer-metastasis-and-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-cd8t-lymphocytes-and-cd68-macrophages-in-assessing-pathologic-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intensity-of-chemotherapy-regimens-for-patients-with-lynch-syndrome-and-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-first-line-atezolizumab-plus-bevacizumab-ab-and-durvalumab-plus-tremelimu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exercise-and-cardiovascular-risk-among-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-between-cardiovascular-disease-risk-and-breast-arterial-calcifications-identified-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-comorbidity-burden-on-overall-survival-in-patients-with-waldenstrom-macroglobul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-related-overall-survival-for-patients-on-durvalumab-for-stage-iii-unresectable-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-digital-educational-and-decision-support-intervention-for-patients-with-advanced-lung-cancer-recei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-neurotoxicity-rating-scale-a-novel-patient-reported-outcome-pro-measure-for-neuro-psycho-beha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-modality-ai-modeling-of-histopathology-images-to-stratify-outcomes-among-patients-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-a-centralized-navigator-led-and-ai-assisted-platform-to-improve-lung-cancer-screening-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-pimicotinib-on-tumor-response-and-physical-function-pf-by-tumor-location-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-epcoritamab-vs-glofitamab-in-relapsedrefractory-diffuse-large-b-cell-lymphom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-value-of-circulating-tumor-cells-ctc-phenotypes-in-crs-hipec-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-role-of-rapid-drug-desensitization-to-treat-cancer-patient-with-infusion-related-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-real-world-survival-outcomes-of-ribociclib-and-abemaciclib-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-d-in-combination-with-bcg-induction-and-maintenance-i-m-therapy-for-bcg-naive-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-tolerability-and-efficacy-of-mesutoclax-icp-248-in-combination-with-azacitidine-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zongertinib-in-her2-altered-colorectal-cancer-a-pooled-analysis-of-colorectal-cancer-patients-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinction-of-flt3-itd-transcriptomic-signature-from-flt3-tkd-and-the-frequency-of-this-signature-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-venetoclax-combined-with-a-10-day-regimen-of-decitabine-in-subjects-with-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/independent-validation-of-a-model-to-predict-early-favorable-psa-response-nadir-model-in-enzalutam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-of-parp-inhibitors-and-taxane-chemotherapy-in-hrr-altered-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-modal-ai-modeling-to-predict-clinical-trial-outcomes-and-benchmarks-pan-ras-versus-kras-g12d-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dominant-chromosomal-abnormalities-in-breast-cancer-metastasis-to-cns-as-compared-with-systemic-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-multi-cancer-risk-from-ehr-data-using-multi-agent-llms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rapid-a-pilot-feasibility-study-of-rapid-dinutuximab-infusion-in-patients-with-relapsedrefractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/olverembatinib-hqp1351-combined-with-blinatumomab-in-patients-with-lymphoid-blast-phase-chronic-my 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chidamide-in-combination-with-chop-in-previously-untreated-peripheral-t-cell-lymphoma-with-t-follicu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-molecular-profile-on-switch-maintenance-to-paclitaxel-plus-ramucirumab-ptx-ram-versus-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-psa-nadir-02-ngml-in-metastatic-castration-sensitive-prostate-cancer-a-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-high-risk-cytogenetic-subgroups-in-multiple-myeloma-using-large-language-artificial-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-rilvegostomig-r-chemotherapy-ctx-in-advanced-biliary-tract-cancer-btc-updated-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-profiling-of-the-tumor-microenvironment-in-pmmrmss-rectal-cancer-treated-with-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-rehabilitation-for-adults-with-soft-tissue-sarcoma-examining-real-world-service-utilizat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-profiling-of-stic-lesions-to-identify-precursor-states-with-genomic-features-of-high-grad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-therapy-with-tifcemailmab-plus-toripalimab-and-chemotherapy-for-resectable-thoracic-es 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-investigations-and-first-in-human-phase-i-trial-of-kp-483-in-solid-tumors-safety-antit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/separating-facts-from-feeds-an-evaluation-of-social-media-videos-on-barretts-esophagus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-over-surgery-the-dominant-prognosticator-in-synchronous-pancreatic-cancer-with-liver-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-local-pixels-to-global-patterns-vision-transformer-based-modeling-for-lung-cancer-classificati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-dependent-divergence-of-immune-prognostic-signatures-in-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-second-line-treatment-patterns-and-outcomes-by-platinum-sensitivity-in-extensive-stage-sm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/what-is-the-optimal-timing-of-radiotherapy-and-immunotherapy-in-lung-cancer-a-meta-analysis-of-rand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-race-and-insurance-status-among-hospitalized-patients-with-pancreatic-cancer-and-prot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enabling-federated-discovery-leveraging-agentic-ai-systems-the-cancer-ai-alliance-and-datavoyager 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-neoadjuvant-nivolumab-nivo-relatlimab-rela-in-high-risk-stage-ii-cutaneous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-lung-cancer-and-infectious-respiratory-diseases-in-us-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/localized-z-ini-butylidenephthalide-biodegradable-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-double-blind-phase-23-study-of-ficerafusp-alfa-bca101-or-placebo-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hair-relaxer-use-and-breast-cancer-risk-by-tumor-molecular-subtypes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-petct-imaging-with-68ga-aky-2519-a-b7-h3-targeted-miniprotein-radioconjugate-to-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-study-of-the-safety-efficacy-and-pharmacokinetics-of-spj-101ca-as-maintenance-therapy-for-newly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dzd6008-a-fourth-generation-egfr-tki-in-pretreated-nsclc-patients-with-iegfr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/abbv-706-as-monotherapy-and-in-combination-with-budigalimab-in-patients-with-relapsedrefractory-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carboplatin-based-versus-cisplatin-based-induction-concurrent-chemoradiotherapy-with-locoregionally 2026-08-24 monthly 0.7